101 related articles for article (PubMed ID: 17431080)
1. Does aripiprazole have a role in treating cognitive impairment in Parkinson's disease?
Singh Ajit S
J Neuropsychiatry Clin Neurosci; 2007; 19(2):205-6. PubMed ID: 17431080
[No Abstract] [Full Text] [Related]
2. Aripiprazole in psychosis associated with Parkinson's disease.
López-Meza E; Ruiz-Chow A; Ramirez-Bermudez J
J Neuropsychiatry Clin Neurosci; 2005; 17(3):421-2. PubMed ID: 16179668
[TBL] [Abstract][Full Text] [Related]
3. Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study.
Wu CL; Yang KC; Wang SJ; Chou YH
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):278-9. PubMed ID: 20854869
[No Abstract] [Full Text] [Related]
4. Aripiprazole: what is the role of dopamine D(2) receptor partial agonism?
Kessler RM
Am J Psychiatry; 2007 Sep; 164(9):1310-2. PubMed ID: 17728411
[No Abstract] [Full Text] [Related]
5. Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Fujino J; Tanaka H; Taniguchi N; Tabushi K
Psychiatry Clin Neurosci; 2010 Feb; 64(1):108-9. PubMed ID: 20416032
[No Abstract] [Full Text] [Related]
6. Aripiprazole-induced tardive dyskinesia: the role of tamoxifen.
Evcimen YA; Evcimen H; Holland J
Am J Psychiatry; 2007 Sep; 164(9):1436-7. PubMed ID: 17728431
[No Abstract] [Full Text] [Related]
7. [Efficacy of aripiprazole on cognitive and behavioral changes in a young woman with systemic lupus erythematosus].
Attademo L; Quartesan R; Moretti P
Clin Ter; 2012; 163(5):e319-23. PubMed ID: 23099980
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic dosing: still a work in progress.
Remington G
Am J Psychiatry; 2010 Jun; 167(6):623-5. PubMed ID: 20516160
[No Abstract] [Full Text] [Related]
9. Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Friedman JH; Berman RM; Goetz CG; Factor SA; Ondo WG; Wojcieszek J; Carson WH; Marcus RN
Mov Disord; 2006 Dec; 21(12):2078-81. PubMed ID: 17013906
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole and Parkinson's disease psychosis.
Schönfeldt-Lecuona C; Connemann BJ
Am J Psychiatry; 2004 Feb; 161(2):373-4. PubMed ID: 14754792
[No Abstract] [Full Text] [Related]
11. Paradoxical motor syndrome following a switch from atypical neuroleptics to aripiprazole.
Koener B; Hermans E; Maloteaux JM; Jean-Jean A; Constant EL
Am J Psychiatry; 2007 Sep; 164(9):1437-8. PubMed ID: 17728432
[No Abstract] [Full Text] [Related]
12. Aripiprazole: striving towards euthymia with a novel mechanism of action.
McIntyre RS
J Affect Disord; 2011 Jan; 128 Suppl 1():S1-2. PubMed ID: 21220075
[No Abstract] [Full Text] [Related]
13. Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain.
Li Z; Ichikawa J; Dai J; Meltzer HY
Eur J Pharmacol; 2004 Jun; 493(1-3):75-83. PubMed ID: 15189766
[TBL] [Abstract][Full Text] [Related]
14. Normalization of prolactin with aripiprazole in a patient with psychotic depression and a comorbid pituitary microadenoma.
Steinhagen CK
Psychosomatics; 2007; 48(4):350-1. PubMed ID: 17600173
[No Abstract] [Full Text] [Related]
15. A low dose of aripiprazole attenuates the subject-rated effects of d-amphetamine.
Stoops WW; Lile JA; Glaser PE; Rush CR
Drug Alcohol Depend; 2006 Sep; 84(2):206-9. PubMed ID: 16540264
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole-induced gray matter growth in a patient with major depressive disorder with panic disorder.
Lai CH
J Clin Psychiatry; 2010 Mar; 71(3):360-2. PubMed ID: 20331938
[No Abstract] [Full Text] [Related]
17. Olfactory disturbance in Parkinson disease.
Singh S; Schwankhaus J
Arch Neurol; 2009 Jun; 66(6):805; author reply 805-6. PubMed ID: 19506149
[No Abstract] [Full Text] [Related]
18. Biological perspectives. Aripiprazole: a third generation of antipsychotics begins?
Keltner NL; Johnson V
Perspect Psychiatr Care; 2002; 38(4):157-9. PubMed ID: 12629954
[TBL] [Abstract][Full Text] [Related]
19. [The antipsychotic drug aripiprazole (ABILIFY)].
Hirose T; Mamiya N; Yamada S; Taguchi M; Kameya T; Kikuchi T
Nihon Yakurigaku Zasshi; 2006 Nov; 128(5):331-45. PubMed ID: 17102579
[No Abstract] [Full Text] [Related]
20. Aripiprazole and adolescent schizophrenia: a simple neuroleptic. No comparison with standard neuroleptic in adolescents.
Prescrire Int; 2009 Dec; 18(104):251. PubMed ID: 20025091
[No Abstract] [Full Text] [Related]
[Next] [New Search]
